Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12590150 | Antibody against Nectin-4 and application thereof | 🖼🧊📄§ | 2026-03-31 | 2041-04-21 | 0 | 31 |
| 12590151 | Anti-human CD19 antibodies with high affinity | 🖼🧊📄§ | 2026-03-31 | 2042-11-03 | 0 | 31 |
| 12590159 | Compositions targeting epidermal growth factor receptor and methods for making and using the same | 🖼🧊📄§ | 2026-03-31 | 2045-02-25 | 0 | 31 |
| 12590156 | Fusion antibody for presenting antigen-derived T cell antigen epitope or peptide containing same on cell surface, and composition comprising same | 🖼🧊📄§ | 2026-03-31 | 2041-02-05 | 0 | 31 |
| 12590158 | Anti-trka antibody or antigen-binding fragment thereof, preparation method thereof, and application thereof | 🖼🧊📄§ | 2026-03-31 | 2042-02-23 | 0 | 31 |
| 12590161 | Anti-C-MPL antibody and use thereof | 🖼🧊📄§ | 2026-03-31 | 2041-11-09 | 0 | 31 |
| 12590166 | CD20 binding molecules and uses thereof | 🖼🧊📄§ | 2026-03-31 | 2041-07-16 | 0 | 31 |
| 12590165 | Methods and materials for identifying and treating membranous nephropathy based on elevated Semaphorin 3B | 🖼🧊📄§ | 2026-03-31 | 2041-03-05 | 0 | 31 |
| 12590163 | Agonistic anti-IL-2R antibodies and methods of use | 🖼🧊📄§ | 2026-03-31 | 2043-08-29 | 0 | 31 |
| 12590169 | 5T4 single domain antibodies and therapeutic compositions thereof | 🖼🧊📄§ | 2026-03-31 | 2039-10-09 | 0 | 31 |
| 12589080 | Enhanced two-stage microparticle-based localized therapeutic delivery system | 🖼🧊📄§ | 2026-03-31 | 2042-06-01 | 0 | 31 |
| 12589079 | Gene delivery system and application thereof in preparation of drugs for treatment of tumors | 🖼🧊📄§ | 2026-03-31 | 2045-05-10 | 0 | 31 |
| 12589086 | Compositions and methods for the treatment of primary biliary cholangitis | 🖼🧊📄§ | 2026-03-31 | 2041-08-25 | 0 | 31 |
| 12589087 | Enantiomer selective action on neurotransmission | 🖼🧊📄§ | 2026-03-31 | 2042-04-01 | 0 | 31 |
| 12589090 | Compounds and methods for the treatment of degenerative disorders | 🖼🧊📄§ | 2026-03-31 | 2040-01-21 | 0 | 31 |
| 12589093 | Plasma kallikrein inhibitors and methods of use thereof in ocular disorders | 🖼🧊📄§ | 2026-03-31 | 2040-04-08 | 0 | 31 |
| 12589097 | Apilimod compositions and methods of use | 🖼🧊📄§ | 2026-03-31 | 2043-08-03 | 0 | 31 |
| 12589099 | Alpha-1062 for treating traumatic brain injury | 🖼🧊📄§ | 2026-03-31 | 2042-11-25 | 0 | 31 |
| 12589106 | Nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier | 🖼🧊📄§ | 2026-03-31 | 2039-12-11 | 0 | 31 |
| 12589108 | Injectable bifunctional hydrogel with antibacterial activity as well as the preparative method and the use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-05-29 | 0 | 31 |
| 12589111 | Pt(IV) chemotherapeutic prodrug and controlled release thereof for treatment of tumors | 🖼🧊📄§ | 2026-03-31 | 2041-11-24 | 0 | 31 |
| 12589112 | Oncolytic virus compositions including IL-15 complex and methods for the treatment of cancer | 🖼🧊📄§ | 2026-03-31 | 2041-01-22 | 0 | 31 |
| 12589118 | Method of prolonging the lifespan of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) using a cerebrolysin® preparation | 🖼🧊📄§ | 2026-03-31 | 2038-08-28 | 0 | 31 |
| 12589117 | Mesenchymal stem cell-derived extracellular vesicles and uses thereof for treating and diagnosing fibrotic diseases | 🖼🧊📄§ | 2026-03-31 | 2042-07-18 | 0 | 31 |
| 12589119 | Treatment of cachexia using fibroblast cells and products thereof | 🖼🧊📄§ | 2026-03-31 | 2039-11-04 | 0 | 31 |
| 12589120 | Methods of treating epidermolysis bullosa with cell-free amniotic fluid compositions | 🖼🧊📄§ | 2026-03-31 | 2042-10-12 | 0 | 31 |
| 12589123 | Compositions and methods comprising clostridium butyricum for the treatment of cancer | 🖼🧊📄§ | 2026-03-31 | 2041-04-20 | 0 | 31 |
| 12589131 | Use of collagen hydrolysate in prevention and/or treatment of food craving | 🖼🧊📄§ | 2026-03-31 | 2043-02-01 | 0 | 31 |
| 12589130 | Aloe extracts for microbial neutralisation | 🖼🧊📄§ | 2026-03-31 | 2043-04-19 | 0 | 31 |
| 12589141 | DNA vaccine capable of effectively treating and/or preventing type 1 diabetes and use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-03-02 | 0 | 31 |
| 12589140 | Antigen-presenting neutrophil-derived dendritic cells and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-01-22 | 0 | 31 |
| 12589142 | HLA tumor antigen peptides of class I and II for treating mammary/breast carcinomas | 🖼🧊📄§ | 2026-03-31 | 2040-06-02 | 0 | 31 |
| 12589143 | Human anti-PD-L1 peptide vaccines and methods of their use | 🖼🧊📄§ | 2026-03-31 | 2040-09-17 | 0 | 31 |
| 12589144 | Combined norovirus and rotavirus vaccine composition and methods of preparation | 🖼🧊📄§ | 2026-03-31 | 2041-01-06 | 0 | 31 |
| 12589146 | Adjuvanted protein vaccines comprising modified full-length spike protein of SARS-CoV-2 composition and methods of use | 🖼🧊📄§ | 2026-03-31 | 2043-02-22 | 0 | 31 |
| 12589151 | T cell modification | 🖼🧊📄§ | 2026-03-31 | 2039-11-29 | 0 | 31 |
| 12589149 | Method of modulating mucosal immunogenicity | 🖼🧊📄§ | 2026-03-31 | 2040-03-18 | 0 | 31 |
| 12589157 | Compositions of drug delivery agents and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2039-03-29 | 0 | 31 |
| 12589160 | Peptide-derived therapeutics targeting KDM5C for the treatment of cancer | 🖼🧊📄§ | 2026-03-31 | 2040-03-12 | 0 | 31 |
| 12589161 | PEGylated synthetic KL4 peptide, compositions and methods thereof | 🖼🧊📄§ | 2026-03-31 | 2040-07-10 | 0 | 31 |
| 12589162 | Trans-cyclooctene prodrug of monomethyl auristatin E | 🖼🧊📄§ | 2026-03-31 | 2041-08-06 | 0 | 31 |
| 12589165 | Methods for treating bladder tumors with viral nanoparticle conjugates and immune checkpoint inhibitors | 🖼🧊📄§ | 2026-03-31 | 2038-04-11 | 0 | 31 |
| 12589166 | Compositions and methods for treating wounds | 🖼🧊📄§ | 2026-03-31 | 2041-05-13 | 0 | 31 |
| 12589069 | Ophthalmic suspension composition | 🖼🧊📄§ | 2026-03-31 | 2042-12-21 | 0 | 31 |
| 12589071 | Suckable and/or melt-in-mouth tablet based on hyaluronic acid and chondroitin sulphate and salts thereof | 🖼🧊📄§ | 2026-03-31 | 2044-02-26 | 0 | 31 |
| 12589064 | Trolox-peptide conjugate and use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-05-06 | 0 | 31 |
| 12588675 | Synergistic antibacterial activity of medium polarity oils in combination with antibacterial agents on bacterial biofilms | 🖼🧊📄§ | 2026-03-31 | 2043-04-03 | 0 | 31 |
| 12588679 | Systems, methods, and apparatuses for disinfection and decontamination | 🖼🧊📄§ | 2026-03-31 | 2043-03-21 | 0 | 31 |
| 12589136 | Viral vectors comprising RDH12 coding regions and methods of treating retinal dystrophies | 🖼🧊📄§ | 2026-03-31 | 2042-08-09 | 0 | 31 |
| 12590304 | Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use | 🖼🧊📄§ | 2026-03-31 | 2040-05-21 | 0 | 31 |